About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside

NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside" src="https://www.abnewswire.com/upload/2025/02/1739994722.jpg" alt="UroGen Pharma Ltd. (NASDAQ: URGN), CS Diagnostics Corp. (OTCQB: CSDX) and Boston Scientific (NYSE: BSX) Advancing Cancer Treatment Technology – More Stocks Inside" width="225" height="225">

CS Diagnostics Corp. (OTCQB: CSDX), a medical technology innovator, continues to advance cancer treatment technology with CS Protect-Hydrogel, a groundbreaking tissue spacer that enhances radiation therapy by protecting healthy tissue. Alongside this milestone, the company has also launched MEDUSA, a next-generation smart disinfectant designed to revolutionize hygiene standards across industries.

CS Protect-Hydrogel: Advancing Cancer Treatment with Cutting-Edge Technology

CS Diagnostics Corp. is advancing cancer treatment technology making breakthrough advancements in oncology with CS Protect-Hydrogel, a tissue spacer used in radiation therapy. The hydrogel works by:

  • Increasing the distance between healthy tissue and cancer cells, reducing radiation damage to healthy organs.
  • Differentiating between malignant and healthy cells, ensuring precision in radiation therapy.
  • Improving recovery outcomes for prostate cancer patients, enhancing overall therapy effectiveness and treatment safety.

Similarly, Boston Scientific (NYSE: BSX) developed SpaceOAR Hydrogel, a hydrogel-based spacer designed to minimize rectal injury during prostate cancer radiation therapy by creating space between the prostate and rectum. Meanwhile, UroGen Pharma Ltd. (NASDAQ: URGN) introduced Jelmyto® (mitomycin for pyelocalyceal solution), the first FDA-approved therapy using RTGel® technology, offering a sustained-release treatment for upper tract urothelial cancer (UTUC) after receiving breakthrough approval in April 2020.

With strong catalysts and strategic business moves, these companies are making headlines and could present exciting opportunities for tech investors looking to capitalize on industry momentum.

CS Diagnostics Corp. (OTCQB: CSDX) was recently featured alongside several high-growth technology companies making strategic advancements in their respective industries, as follows:. Lytus Technologies Ltd. (NASDAQ: LYT), SiNtx Technologies Inc. (NASDAQ: SINT) Interactive Strength Inc. (NASDAQ: TRNR), ReShape Lifesciences Inc. (NASDAQ: RSLS), Cycurion (NASDAQ: CYCU), iQSTEL (OTCQX: IQST) and TruGolf Inc. (NASDAQ: TRUG), Read Entire Article Now!

Meanwhile, CS Diagnostics Corp. (CSDX) continues to make strides in healthcare technology with the launch of MEDUSA, a next-generation disinfectant offering 10-day surface protection, and CS Protect-Hydrogel, an advanced tissue spacer for radiation therapy, further solidifying its position in medical innovation.

MEDUSA: Smart Disinfectant Offering Unmatched Protection

In addition toCS Protect-Hydrogel, MEDUSA, a next-generation smart disinfectant, provides up to 10 days of protection on frequently touched surfaces. Available in two formulations, the alcohol-free version suits public spaces, while the alcohol-based formula is designed for medical settings. Already approved in EU and UAE, MEDUSA awaits U.S. regulatory approval.

Thomas Fahrhoefer, President of CS Diagnostics Corp., says “U.S. launch a major milestone, reinforcing MEDUSA’s role in global hygiene solutions. With the disinfectant market projected at $8.37 billion by 2025 and CS Diagnostics aims to capture a considerable market share, within three years.”

Aggressive Market Expansion Plans

CS Diagnostics Corp. plans to expand into five new markets in 2025, with an aggressive growth strategy targeting 15 global markets within three years. The company’s multi-channel sales approach, including direct sales, strategic partnerships, and sponsorships, is expected to drive significant revenue growth.

As a publicly traded entity on OTCQB, CS Diagnostics Corp. offers investors access to a high-growth opportunity in both medical technology and hygiene solutions.

For further updates on MEDUSA, CS Protect-Hydrogel, and sponsorship deals, investors and stakeholders can follow CS Diagnostics Corp. as it continues to redefine medical and public safety solutions worldwide.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.